Percentage of bloodstream infection due to Escherichia coli resistant in Norway

Norway: Percentage of bloodstream infection due to Escherichia coli resistant was 5.1% in 2021. ▼ Falling

Latest (2021)
5.1%
Change on year
down 3.8%
World rank
50th
of 50 countries
All-time high
6.8%
in 2018
All-time low
5.1%
in 2021
Years of data
6
2016–2021

Percentage of bloodstream infection due to Escherichia coli resistant in Norway, 2016–2021

02462016201820212016: 5.6 %2017: 5.9 %2018: 6.8 %2019: 5.5 %2020: 5.3 %2021: 5.1 %

Source: United Nations Statistics Division, SDG Global Database. Measured in %.

Analysis

Norway recorded 5.1% for percentage of bloodstream infection due to escherichia coli resistant in 2021. That is the lowest value across all 6 years on record.

The figure is down 3.8% on the previous year and down 8.1% over ten years.

Norway ranks 50th of 50 countries on this measure, in the bottom quarter.

Percentage of bloodstream infection due to Escherichia coli resistant in Norway, year by year

Annual values for Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%) in Norway, 2016 to 2021.
Year % Change
2016 5.6%
2017 5.9% +5.2%
2018 6.8% +15.0%
2019 5.5% -18.2%
2020 5.3% -3.4%
2021 5.1% -3.8%

Averages by decade

DecadeAverage LowestHighest Years
2010s 5.9% 5.5% 6.8% 4
2020s 5.2% 5.1% 5.3% 2

Countries ranked near Norway

  1. 47 Netherlands (Kingdom of the) 7.6% compare
  2. 48 Sweden 7.3% compare
  3. 49 Finland 6.7% compare

See the full ranking of 66 places →

More development goals data for Norway

All data for Norway →

Frequently asked questions

What is percentage of bloodstream infection due to escherichia coli resistant in Norway?
Percentage of bloodstream infection due to escherichia coli resistant in Norway was 5.1% in 2021, according to United Nations Statistics Division, SDG Global Database.
What is the highest percentage of bloodstream infection due to escherichia coli resistant recorded in Norway?
The highest recorded value was 6.8% in 2018.
What is the lowest percentage of bloodstream infection due to escherichia coli resistant recorded in Norway?
The lowest recorded value was 5.1% in 2021.
How does Norway rank for percentage of bloodstream infection due to escherichia coli resistant?
Norway ranks 50th out of 50 countries with data for 2021.
Is percentage of bloodstream infection due to escherichia coli resistant rising or falling in Norway?
Over the last ten years it is down 8.1%. The long-run trend across the full record is falling.
Where does this Norway data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 6 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Percentage of bloodstream infection due to Escherichia coli resistant in Norway. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 09 September 2026, from https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-escherichia-coli-resistant-to-3rd-generation/norway/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-escherichia-coli-resistant-to-3rd-generation/norway/">Percentage of bloodstream infection due to Escherichia coli resistant in Norway</a> — Statizoid

About this data

Indicator
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
66 places, 407 data points, 2016–2022
Last refreshed